Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways

Scientific Reports

Volumn 6, Issue , 2016, Pages

  An, Ling Ling ^a   Gorman, Jacob V ^a   Stephens, Geoffrey ^a   Swerdlow, Bonnie ^a   Warrener, Paul ^a   Bonnell, Jessica ^a   Mustelin, Tomas ^a   Fung, Michael ^a   Kolbeck, Roland ^a  

^a Inflammation and Autoimmunity ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD274 PROTEIN, HUMAN; COMPLEMENT COMPONENT C5A; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROGRAMMED DEATH 1 LIGAND 1; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

DRUG EFFECT; HUMAN; MAPK SIGNALING; METABOLISM; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA;

B7-H1 ANTIGEN; COMPLEMENT C5A; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERLEUKIN-10; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; PSEUDOMONAS AERUGINOSA; TRANSFORMING GROWTH FACTOR BETA;

EID: 84987824775     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep33346     Document Type: Article

References (35)

1. Skjeflo, E. W., Christiansen, D., Espevik, T., Nielsen, E. W., Mollnes, T. E. Combined inhibition of complement and CD14 efficiently attenuated the inflammatory response induced by staphylococcus aureus in a human whole blood model. J Immunol. 1, 2857-2864 (2014).
2. Unnewehr, H. et al. Changes and regulation of the C5a receptor on neutrophils during septic shock in humans. J Immunol. 190, 4215-4225 (2013).
3. Monk, P. N., Scola, A. M., Madala, P., Fairlie, D. P. Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol. 152, 429-448 (2007).
4. Ward, P. A. The harmful role of C5a on innate immunity in sepsis. J Innate Immun. 2, 439-445 (2010).
5. Grailer, J. J., Fattahi, F., Dick, R. S., Zetoune, F. S., Ward, P. A. Cutting edge: Critical role for C5aR1s in the development of septic lymphopenia in mice. J Immunol. 194, 868-872 (2015).
6. Weaver, D. J. et al. C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. Eur J Immunol. 40, 710-721 (2010).
7. Strainic, M. G., Shevach, E. M., An, F., Lin, F., Medof, M. E. Absence of signaling into CD4+ cells via C3aR and C5aR1 enables autoinductive TGF-? 1 signaling and induction of Foxp3+ regulatory T cells. Nat Immunol. 2, 162-171 (2013).
8. van der Touw, W. et al. Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells. J Immunol. 190, 5921-5925 (2013).
9. Vadrevu, S. K. et al. Complement C5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche. Cancer Res. 74, 3454-3465 (2014).
10. Engelke, C. et al. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma. J Immunol. 193, 5387-5401 (2014).
11. Bosmann, M., Sarma, J. V., Atefi, G., Zetoune, F. S., Ward, P. A. Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis. FASEB J. 26, 1640-1651 (2012).
12. Boomer, J. S. et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 306, 2594-2605 (2011).
13. Guignant, C. et al. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care. 15, R99 (2011).
14. Chang, K. et al. Targeting the programmed cell death 1: Programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care. 18, R3 (2014).
15. Hewitt, R. E. et al. Immuno-inhibitory PD-L1 can be induced by a peptidoglycan/NOD2 mediated pathway in primary monocytic cells and is deficient in crohn's patients with homozygous NOD2 mutations. Clin Immunol. 143, 162-169 (2012).
16. Mollnes, T. E. et al. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100, 1869-1877 (2002).
17. An, L.-L. et al. Complement C5a potentiates uric acid crystal-induced IL-1? production. Eur J Immunol. 44, 3669-3679 (2014).
18. Reis, E. S. et al. C5aR-dependent cell activation by physiological concentrations of C5adesArg: Insights from a novel label-free cellular assay. J Immunol. 189, 4797-4805 (2012).
19. Eglite S., Plüss K., Dahinden C. A. Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils. J Immunol. 165, 2183-2189 (2000).
20. Croker D. E., Halai R., Fairlie D. P., Cooper, M. A. C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2. Immunol Cell Biol. 91, 625-633 (2013).
21. Crass T., Bautsch W., Cain S. A., Pease J. E., Monk P. N. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand. Biochemistry. 38, 9712-9717 (1999).
22. Brooks, D. G. et al. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. PANS 105, 20428-20433 (2008).
23. Wang, J., Roderiquez, G., Norcross, M. Control of adaptive immune responses by Staphylococcus aureus through IL-10, PD-L1, and TLR2. Sci Rep. 2, 606, doi: 10. 1038/srep00606 (2012).
24. Chiswick, E. L., Mella, J. R., Bernardo, J., Remick D. G. Acute-phase deaths from murine polymicrobial sepsis are characterized by innate immune suppression rather than exhaustion. J Immunol. 195, 3793-3802 (2015).
25. Erridge, C., Pridmore, A., Eley, A., Stewart, J., Poxton I. R. Lipopolysaccharides of bacteroides fragilis, chlamydia trachomatis and pseudomonas aeruginosa signal via toll-like receptor 2. J Med Microbiol. 53, 735-740 (2004).
26. Pene, F. et al. Toll-like receptor 2 deficiency increases resistance to pseudomonas aeruginosa pneumonia in the setting of sepsisinduced immune dysfunction. J Infect Dis. 206, 932-942 (2012).
27. Wang, M. et al. Microbial hijacking of complement-Toll-like receptor crosstalk. Sci Signal. 3, ra11 (2010).
28. Seow, V. et al. Inflammatory Responses Induced by Lipopolysaccharide Are Amplified in Primary Human Monocytes but Suppressed in Macrophages by Complement Protein C5a. J Immunol. 191, 4308-4316 (2013).
29. la Sala, A., Gadina, M., Kelsall, B. L. G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. J Immunol. 175, 2994-2999 (2005).
30. Wrann, C. D. et al. Distinct involvement of p38-, ERK1/2 and PKC signaling pathways in C5a-mediated priming of oxidative burst in phagocytic cells. Cell Immunol. 245, 63-69 (2007).
31. Zhang, X. et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110, 228-236 (2007).
32. Raby, A. C. et al. Toll-like receptor activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5AR12. Eur J Immunol. 41, 2741-2752 (2011).
33. Corrales, L. et al. Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression. J Immunol 189, 4674-4683 (2012).
34. Oppermann, M. et al. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain. J Immunol. 151, 3785-3794 (1993).
35. Bamberg, C. E. et al. The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction. J Biol Chem 285, 7633-7644 (2010).